| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-14 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-07 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 6e-05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |